| Future directions in mucormycosis research. | |
| | |
MedLine Citation:
|
PMID: 22247450 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Mucormycosis has emerged as an important opportunistic infection, especially in severely immunosuppressed hosts. The evolving epidemiology, immunopathogenesis, molecular virulence studies, early diagnosis, and pitfalls in designing clinical studies of mucormycosis are discussed in this article. |
| | |
Authors:
|
Dimitrios P Kontoyiannis; Russell E Lewis; Oliver Lortholary; Oliver Lotholary; Brad Spellberg; Georgios Petrikkos; Emmanuel Roillides; Ashraf Ibrahim; Thomas J Walsh |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural |
Journal Detail:
|
Title: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America Volume: 54 Suppl 1 ISSN: 1537-6591 ISO Abbreviation: Clin. Infect. Dis. Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-01-16 Completed Date: 2012-05-03 Revised Date: 2012-05-17 |
Medline Journal Info:
|
Nlm Unique ID: 9203213 Medline TA: Clin Infect Dis Country: United States |
Other Details:
|
Languages: eng Pagination: S79-85 Citation Subset: IM |
Affiliation:
|
Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. dkontoyi@mdanderson.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antifungal Agents
/
pharmacology Aspergillus / genetics, immunology, pathogenicity* Biomedical Research Early Diagnosis Genome, Fungal Humans Immunocompromised Host Mucormycosis / diagnosis, drug therapy, epidemiology*, pathology Pyrimidines / pharmacology Rhizopus / genetics, immunology, pathogenicity* Risk Factors Triazoles / pharmacology |
| Grant Support | |
ID/Acronym/Agency:
|
CA016672/CA/NCI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Antifungal Agents; 0/Pyrimidines; 0/Triazoles; 0/voriconazole |
| Comments/Corrections | |
Erratum In:
|
Clin Infect Dis. 2012 Apr;54(8):1220 Note: Lotholary, Oliver [corrected to Lortholary, Oliver] |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Combination therapy for mucormycosis: why, what, and how?
Next Document: Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of th...